CompanyRANINasdaqSan Jose, CA

RANI Therapeutics

Rani Therapeutics develops the RaniPill® Capsule, a platform technology for oral delivery of biologics and drugs, replacing subcutaneous or intravenous administration.

Stories only

SEC EDGAR ClinicalTrials.gov ranitherapeutics.com

SCHEDULE 13G/AAug 14Latest SEC filing

Aug 13Latest story

August 2026

Rani Therapeutics reports Q2 2026 results, advances RT-114 oral GLP-1/GLP-2 program

Aug 13Quarterly updateRANI Therapeutics

Rani Therapeutics adds Michelle Gilson to board, names her audit chair

Aug 4PeopleRANI Therapeutics

June 2026

Rani Therapeutics names Nicholas Maestas as new chief financial officer

Jun 29PeopleRANI Therapeutics